In the field of cardiac electrophysiology, atrial fibrillation (AF) poses a significant risk for ischemic stroke, heart failure, and increased mortality.

Jessica Nave, MD, vice president for middle revenue cycle at Emory Healthcare and assistant professor of medicine in Emory’s division of hospital medicine, both in Atlanta, summarized the updated 2025 ...

Background Double sequential defibrillation (DSD) is a promising treatment for patients with out-of-hospital cardiac arrest ...

Wearable video game technology showed promising results with helping chronic stroke survivors recover movement and motor ...

For more than 10 years, the stroke research community has sought and investigated drugs that could enhance or strengthen the ...

The recently published “2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke” from the American Heart Association/American Stroke Association (AHA/ASA) brings several updates ...

In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...

It’s hard to ignore the seismic shifts brought about by algorithm-driven content. Every time you scroll through your social media feed or check your favorite news app, algorithms are diligently at ...

Speaking at WSJ Opinion Live in Washington, D.C., WSJ Editorial Page Editor Paul Gigot and SandboxAQ CEO Jack Hidary discuss Large Quantitative Models (LQMs) and their role in AI applications, the ...

Patients with noncardioembolic ischemic stroke or transient ischemic attack (TIA) are at risk for recurrent stroke. Low factor XI levels are associated with a reduced risk of ischemic stroke.

The results of this obesity medication are literally eye-popping. A new review of adverse effects reports to the FDA between the years 2017 and 2024 reveals that Ozempic and Wegovy have both been ...